Țară: Australia
Limbă: engleză
Sursă: Department of Health (Therapeutic Goods Administration)
Midazolam
Roche Products Pty Ltd
Medicine Registered
HYPNOVEL ® _Midazolam_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about HYPNOVEL. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you using HYPNOVEL against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT BEING GIVEN THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET. You may need to read it again. WHAT HYPNOVEL IS USED FOR HYPNOVEL may be injected as a sedative during some short medical procedures. HYPNOVEL may be given to you by injection before an operation to produce sleepiness or drowsiness and to relieve anxiety. If you are in an intensive care unit, you may receive an infusion of HYPNOVEL over several hours or days as a sedative. HYPNOVEL belongs to a group of medicines called benzodiazepines. They are thought to work by their action on brain chemicals. HYPNOVEL can cause sedation, hypnosis, amnesia and/or anaesthesia, depending on the dose. Your doctor, however, may have prescribed HYPNOVEL for another purpose. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY HYPNOVEL HAS BEEN PRESCRIBED FOR YOU. HYPNOVEL is only given by a doctor trained to use this medicine. If you will be receiving HYPNOVEL during surgery, your doctor will give you the medicine and closely follow your progress. This medicine is available only with a doctor's prescription. BEFORE YOU RECEIVE HYPNOVEL _DO NOT USE HYPNOVEL IF_ • YOU HAVE HAD AN ALLERGIC REACTION TO HYPNOVEL, ANY OTHER BENZODIAZEPINE MEDICINE, OR ANY OF THE INGREDIENTS LISTED AT THE END OF THIS LEAFLET • YOU HAVE SEVERE MUSCLE WEAKNESS, ALSO KNOWN AS MYASTHENIA GRAVIS • YOU HAVE A CONDITION CALLED ACUTE NARROW ANGLE GLAUCOMA • YOU ARE SUFFERING FROM SHOCK, COMA OR ACUTE ALCOHOLIC INTOXICATION IF YOU ARE NOT SURE WHETHER YOU SHOULD BE GIVEN HYPNOVEL, TALK TO YOUR DOCTOR. DO NOT GIVE HYPNOVEL TO CHILDREN. Th Citiți documentul complet
Hypnovel ® PI 130409 1 of 16 CDS 5.0 NAME OF THE MEDICINE HYPNOVEL (_midazolam_) CAS Registry Number: 59467-70-8 Short-acting sleep inducing agent for sedation for short procedures, induction of anaesthesia, and for prolonged sedation in intensive care units. DESCRIPTION The active ingredient of HYPNOVEL is 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a] [1,4] benzodiazepine (midazolam). HYPNOVEL is a benzodiazepine from the imidazobenzodiazepine group. The free base of the active substance of HYPNOVEL is a lipophilic substance with low solubility in water. The basic nitrogen in position 2 of the imidazobenzodiazepine ring enables the active substance of HYPNOVEL to form water-soluble salts with acids. These produce a stable injection solution. The ampoules contain, per mL: midazolam 5 mg or 1 mg (as hydrochloride), sodium chloride, hydrochloric acid (to produce hydrochloride) and sodium hydroxide in water for injection adjusted to pH 3.3. PHARMACOLOGY HYPNOVEL is a short-acting central nervous system depressant which induces sedation, hypnosis, amnesia and anaesthesia. Pharmacokinetic and pharmacodynamic data in chronic intravenous (IV) usage are not available beyond 15 days. PHARMACODYNAMICS The mechanism of action of the benzodiazepines is under continuous investigation. Benzodiazepines appear to intensify the physiological inhibitory mechanisms mediated by gamma-aminobutyric acid (GABA), the most common inhibitory neurotransmitter in the brain. The effects of HYPNOVEL on the CNS are dependent on the dose administered, the route of administration and the presence or absence of other premedicati Citiți documentul complet